SCHEMBL902401

SCHEMBL902401

[CH2]C(CO)CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL157176 0.76
SCHEMBL6749363 0.67
SCHEMBL8534611 0.65
SCHEMBL6036973 0.65
SCHEMBL2477687 0.64
SCHEMBL20529116 0.64
SCHEMBL1761341 0.64
SCHEMBL20237102 0.64
SCHEMBL1033934 0.62
SCHEMBL28743805 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3842074-A1 PROTEIN-DRUG CONJUGATES Philogen S.p.A. (IT) 2021-06-30 EP disclosed
US-9198979-B2 Thiazolidine linker for the conjugation of drugs to antibodies PHILOGEN S.P.A. (IT) 2015-12-01 US disclosed
US-20130309257-A1 Thiazolidine Linker for the Conjugation of Drugs to Antibodies PHILOGEN S.P.A. (IT) 2013-11-21 US disclosed
EP-2621535-A1 THIAZOLIDINE LINKER FOR THE CONJUGATION OF DRUGS TO ANTIBODIES Philogen S.p.A. (IT) 2013-08-07 EP disclosed
WO-2012041451-A1 THIAZOLIDINE LINKER FOR THE CONJUGATION OF DRUGS TO ANTIBODIES PHILOGEN S.P.A. (IT) 2012-04-05 WO disclosed